Type to search

COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027 | Pharmtech Focus
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology | Pharmtech Focus
Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors | Pharmtech Focus